Anika Therapeutics Inc.
ANIKDrug Manufacturers - Specialty & Generic
$21.79+1.11%As of Oct 29vs prior close
- Market cap
- $291.6M
- P/E (TTM)
- –
- P/E (FY1)
- 20.8×
- From 52W high
- −1.09%
- EPS (LTM)
- -$0.27
- Revenue (LTM)
- $120.7M
- Net margin
- -3.14%
- Dividend yield
- 0.00%
Nomior Score
59
Steady ProfileTop 30% of the scored universe
Growth47
Quality39
Value50
Momentum88
Resilience55
Growth
+0.98%revenue a year over 9 fiscal years
YE16 $103.4MLTM $120.7M
Connections
Revenue to profitQ2 YE26
10% of revenue became net profit, up 24 pts on a year.
Who owns it
2funds